Literature DB >> 3935754

The comparative efficacy of antiepileptic drugs for partial and tonic-clonic seizures.

D Chadwick, D M Turnbull.   

Abstract

Studies of the efficacy of anticonvulsant drugs are difficult to undertake and historically have been of poor quality. Randomised comparisons of drugs are few in number, and have failed to detect significant differences between drugs. This is surprising in view of the strong feelings that many clinicians have about the relative efficacy of the drugs they use. A review of the literature emphasises the need for further studies in this field.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3935754      PMCID: PMC1028563          DOI: 10.1136/jnnp.48.11.1073

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  28 in total

1.  Chronic antiepileptic toxicity: a review.

Authors:  E H Reynolds
Journal:  Epilepsia       Date:  1975-06       Impact factor: 5.864

2.  Carbamazepine: behavioral, anticonvulsant and EEG effects in chronically-hospitalized epileptics.

Authors:  G Marjerrison; S M Jedlicki; R P Keogh; W Hrychuk; G M Poulakakis
Journal:  Dis Nerv Syst       Date:  1968-02

3.  Relative anticonvulsant potency of primidone; a double blind comparison.

Authors:  P T White; D Plott; J Norton
Journal:  Arch Neurol       Date:  1966-01

4.  Carbamazepine for epilepsy. A controlled prospective evaluation.

Authors:  J J Cereghino; J T Brock; J C Van Meter; J K Penry; L D Smith; B G White
Journal:  Neurology       Date:  1974-05       Impact factor: 9.910

5.  Sulthiame: evaluation as an anticonvulsant.

Authors:  J R Green; A S Troupin; L M Halperm; P Friel; P Kanarek
Journal:  Epilepsia       Date:  1974-09       Impact factor: 5.864

6.  A comparison of the effectiveness of primidone versus carbamazepine in epileptic outpatients.

Authors:  E A Rodin; C S Rim; H Kitano; R Lewis; P M Rennick
Journal:  J Nerv Ment Dis       Date:  1976-07       Impact factor: 2.254

7.  A comparative controlled study between carbamazepine and diphenylhydantoin in psychomotor epilepsy.

Authors:  N Simonsen; P Z Olsen; V Kühl; M Lund; J Wendelboe
Journal:  Epilepsia       Date:  1976-06       Impact factor: 5.864

8.  Carbamazepine--a double-blind comparison with phenytoin.

Authors:  A Troupin; L M Ojemann; L Halpern; C Dodrill; R Wilkus; P Friel; P Feigl
Journal:  Neurology       Date:  1977-06       Impact factor: 9.910

9.  Phenytoin intoxication induced by sulthiame in epileptic patients.

Authors:  G W Houghton; A Richens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-03       Impact factor: 10.154

10.  [The anti-epileptic and psychotropic properties of carbamazepine (Tegretol)].

Authors:  P Rajotte; W Jilek; L Jilek; A Perales; N Giard; J M Bordeleau; L Tétreault
Journal:  Union Med Can       Date:  1967-10
View more
  4 in total

1.  A comparative study of progabide, valproate, and placebo as add-on therapy in patients with refractory epilepsy.

Authors:  P Crawford; D Chadwick
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-11       Impact factor: 10.154

2.  The contribution of the measurement of seizure severity to quality of life research.

Authors:  D Smith; G A Baker; A Jacoby; D W Chadwick
Journal:  Qual Life Res       Date:  1995-04       Impact factor: 4.147

Review 3.  Epilepsy.

Authors:  D Chadwick
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-03       Impact factor: 10.154

Review 4.  The management of epilepsy in the 1990s. Acquisitions, uncertainties and priorities for future research.

Authors:  E Beghi; E Perucca
Journal:  Drugs       Date:  1995-05       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.